Cancer Ag 19-9:ACnc:Pt:Ser/Plas:Qn:IA

Preferred Label : Cancer Ag 19-9:ACnc:Pt:Ser/Plas:Qn:IA;

LOINC status : ACTIVE;

LOINC display name : Cancer Ag 19-9 IA Qn;

LOINC long common name : Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay;

LOINC short name : Cancer Ag19-9 SerPl IA-aCnc;

LOINC description : This term was created for, but is not limited in use to, bioMerieux's VIDAS CA 19-9 assay, which is intended for the quantitative measurement of the 1116- NS-19-9 reactive antigenic determinants in human serum or plasma.;

Details

Origin ID

83084-4;

UMLS CUI

C4298245;

Has component
- Cancer [LOINC component]
- Cancer Ag 19-9 [LOINC component]
Has method
- Immunoassay [LOINC method]
Has property
- Arbitrary Concentration [LOINC Property]
Has system
- Plasma [LOINC System]
- Serum [LOINC System]
- Serum or Plasma [LOINC System]
Has time aspect
- Point in time (spot) [LOINC time aspect]
Semantic type(s)
- Clinical Attribute [UMLS semantic type]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients